CTMC

Houston, TX
National Center
CAR-T Cell Therapy Gene Editing
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: CTMC

Signal Score
63.0/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Houston, TX
Modalities
CAR-T, Cell Therapy, Gene Editing
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About CTMC

MD Anderson-affiliated CGT manufacturing center.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: MD Anderson Cancer Center
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: MD Anderson Cancer Center
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Houston, TX
Modalities: CAR-T, Cell Therapy, Gene Editing
Capacity assessment: 58.0/100
Sites: Houston, TX
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Houston, TX
Modalities: CAR-T, Cell Therapy, Gene Editing
Capacity assessment: 58.0/100

Frequently Asked Questions About CTMC

What is CTMC's CDMO Signal Score?
CTMC has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating CTMC for a manufacturing program?
Use the free AI matchmaker to compare CTMC against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs → Gene Editing CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 80.2
CAR-T, Cell Therapy, iPSC, Gene Editing
GenScript
Piscataway, NJ
Signal Score: 65.5
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
Rose BioSolutions
Rockville, MD
Plasmid DNA, AAV, Lentiviral, Adenoviral, CAR-T, Cell Therapy, Gene Editing, Cell Solutions / Starting Materials